Pharmaceutical Supply – Etomidate Injection (NDC: 00143-9507-10)

The contract entails the supply and delivery of Etomidate Injection, identified by NSN 6505-01-533-4392 and NDC 00143-9507-10, a short-acting intravenous anesthetic used for induction of anesthesia, to Fort Bragg, North Carolina. All units must be provided in sealed, properly labeled packages conforming to federal pharmaceutical standards, ensuring integrity and traceability throughout the supply chain. Delivery is governed by FOB Destination terms, meaning the supplier assumes all risks and responsibilities until the product arrives at the specified military installation, requiring precise logistics planning and compliance with Defense Logistics Agency requirements. This subcontract, classified under NAICS code 325412 for pharmaceutical preparation manufacturing, is issued by the Department of Defense through the Defense Logistics Agency and is scheduled for performance beginning in 2026. The contract does not specify a solicitation number or set-aside details, indicating it may be part of a broader procurement framework. The absence of point-of-contact information and detailed office addresses suggests the handling is centralized under DLA’s procurement systems, with all obligations and compliance protocols managed through official DIBBS channels. The delivery location and pharmaceutical nature of the item imply strict adherence to military medical supply protocols, cold chain requirements, and quality control standards for clinical use in military healthcare settings.